Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort - 08/11/14
, Hana Müllerova b , Alvar Agusti c , Julie C. Yates d , Ruth Tal-Singer e , Stephen I. Rennard f , Jørgen Vestbo g , Emiel F.M. Wouters a, h on behalf of the
Eclipse Investigators
Summary |
Background |
Depression is highly prevalent among patients with Chronic Obstructive Pulmonary Disease (COPD). The relationship of depression with systemic inflammation in COPD remains unknown. The objective of this observational study was to compare depression scores at baseline and after 36 months follow-up between COPD patients with persistent systemic inflammation (PSI) and never inflamed patients (NI) in the ECLIPSE cohort.
Methods |
The ECLIPSE study included 2164 COPD patients. Parameters assessed at baseline and at 36 months follow-up included: demographics, clinical characteristics and symptoms of depression (Center for Epidemiologic Studies of Depression, CES-D). Patients classified as NI had zero and patients with PSI had ≥2 inflammatory biomarkers (white blood cell count, hsCRP, IL-6, and fibrinogen) in the upper quartile, at baseline and 12 months later.
Findings |
350 patients (29.1%) were NI and 131 patients (10.9%) had PSI. At baseline, mean CES-D score was higher in patients with PSI than in NI patients (11.7 (8.6) vs. 9.2 (8.9) points, p = 0.01). Differences were not confirmed after adjustment for possible confounders (β (95% CI) = 0.02 (−3.87 to 15.29), adjusted p = 0.98). At 36 months follow-up, CES-D scores were comparable in PSI and NI patients (12.2 (9.3) vs. 10.5 (9.0) points, p = 0.08) as were their temporal changes (0.5 (8.3) vs. 1.3 (7.9) points, p = 0.30).
Conclusion |
The ECLIPSE study does not support a strong relationship between PSI and symptoms of depression at baseline and after 36 months follow-up in COPD.
Funding |
The study was sponsored by GlaxoSmithKline.
Le texte complet de cet article est disponible en PDF.Keywords : Chronic Obstructive Pulmonary Disease, Depressive disorder, Psychological symptoms, Comorbidities, Biomarkers
Abbreviations : PSI, NI
Plan
Vol 108 - N° 11
P. 1647-1654 - novembre 2014 Retour au numéro
Article précédent
- The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation
- George Habib, Yusri Dar-Esaif, Hashim Bishara, Suheil Artul, Samih Badarny, Mark Chernin, Adel Jabbour
- Clinical implications of correlation between peripheral eosinophil count and serum levels of IL-5 and tryptase in acute eosinophilic pneumonia
- Byung Woo Jhun, Se Jin Kim, Kang Kim, Ji Eun Lee, Duck Jin Hong
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?